Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

Objective: To investigate racial differences in smoking patterns and lung function in patients with advanced COPD. Design: Retrospective record review of patients with advanced COPD. Setting ...

Chronic obstructive pulmonary disease (COPD) is a progressive and ultimately fatal chronic illness that is the fourth leading cause of death in the world. People with advanced COPD experience ...

Chronic obstructive pulmonary disease (COPD) is a challenge, but it isn’t one that needs to get in the way of a regular life. With a good diet, the right care, and some patience, you can live ...

The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated.

Due to the destructive nature of COPD on patients’ lungs and well-being, timely diagnosis is key, and integrating spirometry ...

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated. Pulmonary ...